Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline"

Elena Gonzalez Rodriguez¹, Olivier Lamy^{1

2}

Affiliations

¹ Bone Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
² Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Comment

Elena Gonzalez Rodriguez et al. J Clin Endocrinol Metab. 2019.

. 2019 Aug 1;104(8):3535-3536.

doi: 10.1210/jc.2019-00747.

Elena Gonzalez Rodriguez¹, Olivier Lamy^{1

2}

¹ Bone Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
² Service of Internal Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

No abstract available

Comment in

Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
Eastell R, Rosen CJ. Eastell R, et al. J Clin Endocrinol Metab. 2019 Aug 1;104(8):3537-3538. doi: 10.1210/jc.2019-00777. J Clin Endocrinol Metab. 2019. PMID: 30998238 No abstract available.
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
Sugiyama T. Sugiyama T. J Clin Endocrinol Metab. 2019 Nov 1;104(11):5181-5182. doi: 10.1210/jc.2019-01017. J Clin Endocrinol Metab. 2019. PMID: 31095312 No abstract available.

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Eastell R, et al. J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221. J Clin Endocrinol Metab. 2019. PMID: 30907953